Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Nov;22(5):521–526. doi: 10.1111/j.1365-2125.1986.tb02930.x

Plasma [3H]-noradrenaline kinetics and blood pressure following regular, moderate ethanol consumption.

L G Howes, A MacGilchrist, C Hawksby, D Sumner, J L Reid
PMCID: PMC1401178  PMID: 3790399

Abstract

Normotensive male volunteers (n = 8) either abstained from ethanol for 4 days or consumed 66 g of ethanol per day in an open, crossed, random order study. Mean arterial pressures rose by an average of 5.4 mmHg following the ethanol phase of the study (P less than 0.001). Plasma noradrenaline (NA) concentration was higher during ethanol ingestion (P less than 0.01), principally because of a significant reduction in NA clearance of -1.51 l min-1 m-2 (P less than 0.05). In contrast, NA spillover or release rates did not significantly differ between the two study periods. Total plasma calcium levels were significantly lower (P less than 0.05) following the ethanol compared to the control period. These data do not appear to support the proposition that regular alcohol consumption raises blood pressure by producing a generalised increase in sympathetic activity.

Full text

PDF
521

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arkwright P. D., Beilin L. J., Vandongen R., Rouse I. A., Lalor C. The pressor effect of moderate alcohol consumption in man: a search for mechanisms. Circulation. 1982 Sep;66(3):515–519. doi: 10.1161/01.cir.66.3.515. [DOI] [PubMed] [Google Scholar]
  2. Arkwright P. D., Beilin L. J., Vandongen R., Rouse I. L., Masarei J. R. Plasma calcium and cortisol as predisposing factors to alcohol related blood pressure elevation. J Hypertens. 1984 Aug;2(4):387–392. [PubMed] [Google Scholar]
  3. Beevers D. B., Bannan L. T., Saunders J. B., Paton A., Walters J. R. Alcohol and hypertension. Contrib Nephrol. 1982;30:92–97. [PubMed] [Google Scholar]
  4. Best J. D., Halter J. B. Blood pressure and norepinephrine spillover during propranolol infusion in humans. Am J Physiol. 1985 Apr;248(4 Pt 2):R400–R406. doi: 10.1152/ajpregu.1985.248.4.R400. [DOI] [PubMed] [Google Scholar]
  5. Cohen L. B., Sellers E. M., Sellers E. A., Flattery K. V. Ethanol and sympathetic denervation effects on rat adrenal catecholamine turnover. J Pharmacol Exp Ther. 1980 Mar;212(3):425–430. [PubMed] [Google Scholar]
  6. Eisenhofer G., Lambie D. G., Johnson R. H. Effects of ethanol on plasma catecholamines and norepinephrine clearance. Clin Pharmacol Ther. 1983 Aug;34(2):143–147. doi: 10.1038/clpt.1983.143. [DOI] [PubMed] [Google Scholar]
  7. Esler M. Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics. Clin Sci (Lond) 1982 Mar;62(3):247–254. doi: 10.1042/cs0620247. [DOI] [PubMed] [Google Scholar]
  8. Esler M., Jackman G., Bobik A., Kelleher D., Jennings G., Leonard P., Skews H., Korner P. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci. 1979 Oct 22;25(17):1461–1470. doi: 10.1016/0024-3205(79)90371-0. [DOI] [PubMed] [Google Scholar]
  9. Ghione S., Palombo C., Pellegrini M., Fommei E., Pilo A., Donato L. The kinetics of plasma noradrenaline in normal and hypertensive subjects. Clin Sci Mol Med Suppl. 1978 Dec;4:89s–92s. doi: 10.1042/cs055089s. [DOI] [PubMed] [Google Scholar]
  10. Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Howes L. G., MacGilchrist A., Hawksby C., Sumner D., Reid J. L. An improved approach for the determination of plasma [3H]noradrenaline kinetics using high-performance liquid chromatography. Clin Sci (Lond) 1986 Aug;71(2):211–215. doi: 10.1042/cs0710211. [DOI] [PubMed] [Google Scholar]
  12. Howes L. G., Miller S., Reid J. L. Simultaneous assay of 3,4-dihydroxyphenylethylene glycol and norepinephrine in human plasma by high-performance liquid chromatography with electrochemical detection. J Chromatogr. 1985 Mar 22;338(2):401–403. doi: 10.1016/0378-4347(85)80111-0. [DOI] [PubMed] [Google Scholar]
  13. Howes L. G., Reid J. L. Decreased vascular responsiveness to noradrenaline following regular ethanol consumption. Br J Clin Pharmacol. 1985 Dec;20(6):669–674. doi: 10.1111/j.1365-2125.1985.tb05126.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ogata M., Mendelson J. H., Mello N. K., Majchrowicz E. Adrenal function and alcoholism. II. Catecholamines. Psychosom Med. 1971 Mar-Apr;33(2):159–180. doi: 10.1097/00006842-197103000-00007. [DOI] [PubMed] [Google Scholar]
  15. Pohorecky L. A. Effects of ethanol on central and peripheral noradrenergic neurons. J Pharmacol Exp Ther. 1974 May;189(2):380–391. [PubMed] [Google Scholar]
  16. Potter J. F., Bannan L. T., Saunders J. B., Ingram M. C., Beevers D. G. Blood pressure and pressor mechanisms during alcohol withdrawal. J Hypertens Suppl. 1983 Dec;1(2):97–99. [PubMed] [Google Scholar]
  17. Potter J. F., Beevers D. G. Pressor effect of alcohol in hypertension. Lancet. 1984 Jan 21;1(8369):119–122. doi: 10.1016/s0140-6736(84)90060-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES